A drug-eluting balloon is a non-stent technology in which the vessel wall processes the effective homogeneous delivery of anti-proliferative drugs via an inflated balloon. Healthcare infrastructure has undergone significant changes in the last decade as technology has proliferated and healthcare research has expanded significantly. Rising obesity, an ageing population, and an increase in the prevalence of coronary artery disease are some of the factors driving demand for drug-eluting balloon catheters. When stents are used in conjunction with a balloon catheter, they are referred to as balloon expandable stents, as opposed to self-expandable stents, which are typically made of nitinol alloy.Get Access to A Free Sample Copy of Our Latest Report – https://www.globalinsightservices.com/request-sample/GIS24323
Market Drivers and Trends
The increasing prevalence of coronary artery disease among people all over the world is the primary driver of the industry’s growth. For example, according to the World Health Organization, approximately 3.8 million men and 4.4 million women will die from coronary heart disease. Furthermore, the number of deaths between the ages of 15 and 59 is approximately 1332 million, and the number of deaths over the age of 60 is approximately 5825 million. Furthermore, according to the Centers for Disease Control and Prevention, coronary heart disease will be the most common type of heart disease in upcoming years, killing 382,820 people globally.
Furthermore, the industry’s growth will be driven by increasing prevalence of diabetes. According to the World Health Organization’s October 2018 report, diabetes is responsible for approximately 1.6 million deaths worldwide. According to the Centers for Disease Control and Prevention, diabetes has affected 537 million adults (20-79 years) worldwide in 2021, accounting for one in every ten people. China has the most diabetics in the world, with approximately 141 million people suffering from the disease. Diabetes is expected to affect approximately 174 million people in China by 2045. These factors are expected to drive the growth of the global Drug-Eluting Balloon Catheters Market.
Read Full Research Report – https://www.globalinsightservices.com/reports/drug-eluting-balloon-catheters-market/
Market Restraints and Challenges
Over the period, the high risk of infections associated with drug-eluting balloon catheters is expected to hinder growth in the global Drug-Eluting Balloon Catheters Market. Despite increasing product adoption factors such as catheterization procedures and balloon catheters may have a negative impact on the industry landscape. In May 2017, Abbott recalled three balloon catheters due to difficulty removing the balloon sheath, resulting in 19 reports of injury and one death. This is a potential restraint hindering the global Drug-Eluting Balloon Catheters Market growth.
Major Players in the Global Drug-Eluting Balloon Catheters Market
The key players studied in the global Drug-Eluting Balloon Catheters Market are B. Braun Melsungen AG, Medtronic, BD Interventional, Biotronik AG, Eurocor GmbH, MedAlliance, Boston Scientific Corporation, Lepu Medical Technology Co Ltd, iVascular S.L.U, and Cook Medical among others.
Request For Customization – https://www.globalinsightservices.com/request-customization/GIS24323
COVID-19 Impact
The COVID-19 pandemic and lockdown in various countries around the world has had a negative impact on businesses in all sectors. The COVID-19 pandemic has impacted the entire healthcare supply chain, owing to strict lockdown in several regions. Similarly, because of the delayed peripheral, interventional, and cardiovascular surgical procedures caused by the COVID-19 pandemic, the drug-eluting balloon catheters industry suffered greatly. Many countries prioritized the treatment of coronavirus patients in order to keep the system from becoming overburdened by the high case count. All non-emergency procedures, including catheterization, were also postponed in order to redirect resources to pandemic patient treatment and care.
Global Drug-Eluting Balloon Catheters Market Segmentation
By Product
- Coronary Artery Disease
- Peripheral Vascular Disease
By End-User
- Hospitals and Clinics
- Ambulatory surgical centers
- Catheterization Laboratories
Buy Now – https://www.globalinsightservices.com/checkout/single_user/GIS24323
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
New Report Published by Global Insight Services –https://www.globalinsightservices.com/reports/hydrogen-projects-database/?utm_source=utm_source%3Dopenpr_pranali_pawar&utm_medium=member_desktop
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/